Literature DB >> 21334407

Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis.

Koji Kitamura1, Etsuro Hatano, Tatsuya Higashi, Masato Narita, Satoru Seo, Yuji Nakamoto, Kenya Yamanaka, Hiromitsu Nagata, Kojiro Taura, Kentaro Yasuchika, Takashi Nitta, Shinji Uemoto.   

Abstract

BACKGROUND & AIMS: This study investigated the relationship between tumor proliferative activity and the grade of tumor glucose metabolism or angiogenesis in hepatocellular carcinoma (HCC).
METHODS: The study was performed as a retrospective analysis of 63 patients with HCC who underwent fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) as a preoperative examination prior to liver resection. Tumor proliferative activity was evaluated by the Ki-67 labeling index (LI). The grade of tumor glucose metabolism was evaluated by measuring the protein expression level of glucose transporter (GLUT)-1, expression level of pyruvate kinase type M2 (PKM2) mRNA, and FDG uptake. The grade of tumor angiogenesis was evaluated by the protein expression level of vascular endothelial growth factor (VEGF) and tumor microvessel density.
RESULTS: All patients were divided into tertiles according to the Ki-67 LI: the low LI group (n = 21), the intermediate LI group (n = 21), and the high LI group (n = 21). The high LI group showed a tendency to have advanced tumor stage, and lower disease-free survival and overall survival rates than the low LI and the intermediate LI groups. The expression grade of GLUT-1, PKM2 mRNA, and FDG uptake gradually increased with the Ki-67 LI. On the other hand, the protein expression grade of VEGF and microvessel density was paradoxically decreased with the Ki-67 LI.
CONCLUSIONS: These data suggest that (1) the proliferative activity of a resected specimen predicted the prognosis in patients with HCC; (2) the proliferative activity was closely correlated with the glucose metabolism, but not with angiogenesis.
Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21334407     DOI: 10.1016/j.jhep.2011.01.038

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  55 in total

Review 1.  Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis.

Authors:  Yihuan Luo; Fanghui Ren; Yongru Liu; Zhenhong Shi; Zhong Tan; Huojie Xiong; Yiwu Dang; Gang Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Clinical utility and limitations of FDG PET in detecting recurrent hepatocellular carcinoma in postoperative patients.

Authors:  Nobuyuki Hayakawa; Yuji Nakamoto; Koya Nakatani; Etsuro Hatano; Satoru Seo; Tatsuya Higashi; Tsuneo Saga; Shinji Uemoto; Kaori Togashi
Journal:  Int J Clin Oncol       Date:  2013-12-25       Impact factor: 3.402

3.  18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Misu Lee; Jeong Yong Jeon; Micheal L Neugent; Jung-Whan Kim; Mijin Yun
Journal:  Clin Exp Metastasis       Date:  2017-04-20       Impact factor: 5.150

Review 4.  Living donor liver transplantation for hepatocellular carcinoma achieves better outcomes.

Authors:  Chih-Che Lin; Chao-Long Chen
Journal:  Hepatobiliary Surg Nutr       Date:  2016-10       Impact factor: 7.293

5.  Preoperative normalized iodine concentration derived from spectral CT is correlated with early recurrence of hepatocellular carcinoma after curative resection.

Authors:  Ningbin Luo; Wenzhu Li; Jisheng Xie; Danhui Fu; Lidong Liu; Xiangyang Huang; Danke Su; Guanqiao Jin
Journal:  Eur Radiol       Date:  2020-10-09       Impact factor: 5.315

Review 6.  Mechanistic understanding of β-cryptoxanthin and lycopene in cancer prevention in animal models.

Authors:  Ji Ye Lim; Xiang-Dong Wang
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-02-05       Impact factor: 4.698

7.  Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growth.

Authors:  Barbara Chiavarina; Diana Whitaker-Menezes; Ubaldo E Martinez-Outschoorn; Agnieszka K Witkiewicz; Ruth Birbe; Anthony Howell; Richard G Pestell; Johanna Smith; Rene Daniel; Federica Sotgia; Michael P Lisanti
Journal:  Cancer Biol Ther       Date:  2011-12-15       Impact factor: 4.742

8.  Regulatory circuit of PKM2/NF-κB/miR-148a/152-modulated tumor angiogenesis and cancer progression.

Authors:  Q Xu; L-Z Liu; Y Yin; J He; Q Li; X Qian; Y You; Z Lu; S C Peiper; Y Shu; B-H Jiang
Journal:  Oncogene       Date:  2015-02-23       Impact factor: 9.867

9.  Paracrine Hedgehog signaling drives metabolic changes in hepatocellular carcinoma.

Authors:  Isaac S Chan; Cynthia D Guy; Yuping Chen; Jiuyi Lu; Marzena Swiderska-Syn; Gregory A Michelotti; Gamze Karaca; Guanhua Xie; Leandi Krüger; Wing-Kin Syn; Blair R Anderson; Thiago A Pereira; Steve S Choi; Albert S Baldwin; Anna Mae Diehl
Journal:  Cancer Res       Date:  2012-10-12       Impact factor: 12.701

10.  Over expression of hyaluronan promotes progression of HCC via CD44-mediated pyruvate kinase M2 nuclear translocation.

Authors:  Jing-Huan Li; Ying-Cong Wang; Cheng-Dong Qin; Rong-Rong Yao; Rui Zhang; Yan Wang; Xiao-Ying Xie; Lan Zhang; Yan-Hong Wang; Zheng-Gang Ren
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.